UNIS-BIO PHARMA LLC – Trademark Portfolio
Entity Type: 16
UNIS-BIO PHARMA LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include BULCLI, LILYPENY, and POWER BUFF. The owner is based in RICHARDSON, TX.
1303 E ARAPAHO RD
STE 150B
RICHARDSON, TX 75081
Showing of trademarks Trademarks
Trademark Classifications
UNIS-BIO PHARMA LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does UNIS-BIO PHARMA LLC have?
UNIS-BIO PHARMA LLC has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 1 abandoned.
What trademark classes does UNIS-BIO PHARMA LLC file in?
UNIS-BIO PHARMA LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 30 (Staple Foods), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are UNIS-BIO PHARMA LLC's most well-known trademarks?
UNIS-BIO PHARMA LLC's registered trademark portfolio includes well-known marks such as BULCLI, LILYPENY, and POWER BUFF. These are among 5 currently registered trademarks in the portfolio.
What is UNIS-BIO PHARMA LLC's trademark registration success rate?
UNIS-BIO PHARMA LLC has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.